![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 34, 23808-23813, August 20, 1999
From the Department of Microbiology, Monash University, Clayton,
Victoria 3168, Australia and the Plasmodium falciparum erythrocyte
membrane protein 1 (PfEMP1) clusters at electron-dense knob-like
structures on the surface of malaria-infected red blood cells and
mediates their adhesion to the vascular endothelium. In parasites
lacking knobs, vascular adhesion is less efficient, and infected red
cells are not able to immobilize successfully under hemodynamic flow
conditions even though PfEMP1 is still present on the exterior of the
infected red cell. We examined the interaction between the
knob-associated histidine-rich protein (KAHRP), the parasite protein
upon which knob formation is dependent, and PfEMP1, and we show
evidence of a direct interaction between KAHRP and the cytoplasmic
region of PfEMP1 (VARC). We have identified three fragments of KAHRP which bind VARC. Two of these KAHRP fragments (K1A and K2A) interact with VARC with binding affinities (KD(kin)) of
1 × 10 Plasmodium falciparum causes the most severe form of
human malaria and is responsible for at least two million deaths
worldwide each year. The excessive pathogenicity of P. falciparum appears to be related to an ability to cause infected
red blood cells to adhere to vascular endothelium and sequester in the
microvasculature of a variety of organs (1). Knob-like, electron-dense
structures located at the membrane surface of infected red cells are
the points of adhesion between infected red cells and the vascular endothelium (2). Knob formation is critically dependent upon the
expression of the knob-associated histidine-rich protein
(KAHRP)1 (3), an 85-105-kDa
parasite protein that associates with the red cell cytoskeletal
proteins spectrin and actin (4). In addition to KAHRP, several other
parasite proteins are also present in knobs including the mature
parasite-infected erythrocyte surface antigen (MESA), P. falciparum erythrocyte membrane protein 3 (PfEMP3) and P. falciparum erythrocyte membrane protein 1 (PfEMP1) (5). PfEMP1 is
a large (200-350 kDa) antigenically diverse parasite protein that is
exported from the intracellular parasite and inserted into the red cell
membrane (6, 7) where it clusters over the knobs (8). It is the ligand
on the surface of infected red cells which mediates adhesion to a
number of endothelial cell receptors including intercellular adhesion
molecule 1, CD36, and thrombospondin (9), resulting in the accumulation
of infected red cells in the microvasculature (2).
PfEMP1 proteins are encoded by var genes, a highly variable
gene family with some 30-50 copies present per parasite genome (10).
The first exon of a var gene encodes both the ectodomain and
the transmembrane domain of PfEMP1 (11); the second exon encodes a
relatively conserved cytoplasmic domain (VARC), also called the acidic
terminal segment (11). Amino acid sequence alignments of VARC regions
from various var genes have shown that there is general
conservation with some diversity among var genes which
allows assignment of the highly charged VARC sequences into two general
families or into intermediate hybrid groups (12).
The mechanism by which PfEMP1 is anchored into the membrane of infected
red cells has not yet been elucidated, but detergent extraction
experiments of infected red cells have revealed that PfEMP1 extraction
requires ionic detergents such as SDS (13), suggesting that PfEMP1 is
associated with the cytoskeleton, perhaps by interaction of the VARC
domain with the various components of the knobs. Previous studies have
shown that parasites lacking a functional KAHRP gene, resulting either
from loss of the structural gene by spontaneous deletion or by targeted
gene disruption (14, 15), do not express knobs (termed knobless) and
show defects in their ability to adhere to endothelial cells (15, 16). Knobless infected red cells still express PfEMP1 on their membrane surface and are capable of adhering at normal levels when tested in
static assays. Remarkably, however, when tested under flow conditions
that mimic those in the vasculature in vivo (15) they show a
grossly reduced ability to adhere. This decreased adhesiveness
under flow can be best interpreted as being the result of defective
anchoring of PfEMP1 into the membrane of knobless infected red cells,
perhaps due to the absence of an anchoring interaction.
In this study we have examined whether VARC may bind to KAHRP using
recombinantly expressed fusion fragments of KAHRP and VARC. The protein
binding data obtained demonstrate that VARC binds to at least two
distinct regions of the KAHRP protein with dissociation constants
(KD) comparable to those of other important protein-protein interactions among red cell cytoskeletal proteins and
between red cell cytoskeletal proteins and parasite proteins in
infected red cells. Experiments using smaller recombinant fusion proteins and deletion mutant proteins have mapped the two main VARC
binding regions of KAHRP to regions of 63 and 70 amino acid residues, respectively.
Construction of Protein Expression Clones in pGEX--
The VARC
domain of PfEMP1 was amplified from genomic P. falciparum
ItG2 DNA by PCR using oligonucleotide primers p375 and p376 (Table
I), designed with reference to the
nucleotide sequence of var2 (11). Regions of the second exon
of KAHRP were amplified by PCR using the oligonucleotide primers listed
in Table I. PCR products were cloned into the Escherichia
coli pGEX protein expression plasmids (Amersham Pharmacia
Biotech), and the nucleotide sequence and reading frame of cloned
inserts were confirmed by automated dye terminator sequencing.
Expression and Purification of Recombinant GST Fusion
Proteins--
VARC and regions of KAHRP were expressed as glutathione
S-transferase (GST) fusion proteins in E. coli
BL21(DE3) cells (Novagen Inc., Milwaukee, WI) and purified using
standard techniques (17). The purified GST fusion proteins were
dialyzed overnight against phosphate-buffered saline (PBS; 10 mM
Na2HPO4/NaH2PO4, pH
7.4, containing 0.15 M NaCl) at 4 °C, with one buffer
change before proteins were concentrated by centrifugal filtration.
Total protein concentrations were determined by Bio-Rad protein assays.
In Vitro Binding Assays--
Binding assays were performed using
an assay based on that described previously by Bennett et
al. (17). Briefly, KAHRP GST fusion proteins were coated into the
wells of 96-well microtiter plates (Dynatech Laboratories, Inc.,
Chantilly, VA). For each protein, wells were coated in triplicate using
~3 µg of protein/well and incubated at 4 °C overnight. After
blocking with 5% (w/v) BSA in PBS overnight at 4 °C and washing
twice with PBS, 5 µg of GST-VARC1, diluted in PBS containing 0.05%
(v/v) Tween 20, was added to each well and incubated at 4 °C
overnight. Wells were washed five times with PBS, and then proteins
were stripped from the wells using heated (70 °C) reducing SDS
sample buffer and resolved by SDS-polyacrylamide gel electrophoresis in
10% polyacrylamide gels. Proteins were transferred to
Polyscreen® polyvinylidene difluoride transfer membrane
(NEN Life Science Products) and interacting GST-VARC1 proteins
immunoblotted using a polyclonal rabbit anti-GST-VARC1 antiserum
(preabsorbed for anti-GST reactivity) followed by a sheep anti-rabbit
Ig-horseradish peroxidase conjugate. Detection was performed using NEN
Renaissance Western blot chemiluminescence reagent according to the
manufacturer's instructions (NEN Life Science Products) and visualized
on x-ray film.
Binding Assays Using Resonant Mirror
Detection--
Protein-protein interactions were studied using the
resonant mirror detection method (18-20) of the IAsysTM (Affinity
Sensors, Cambridge, U. K.). Two dissociation constants
(KD(kin) and
KD(Scat)) were determined by kinetic and
Scatchard analysis using the results from the binding assay as outlined below (21). GST, BSA, and GST-VARC1 were immobilized on an aminosilane cuvette, which had been activated with
bis-(sulfosuccinimidyl) suberate (Pierce Chemical Co.)
according to the manufacturer's instructions, with slight
modifications. After immobilization the cuvette was blocked with 1%
(w/v) BSA in PBS. All experimental procedures were carried out in PBS
containing 0.05% (v/v) Tween 20 at 25 °C under constant stirring.
Then both the association rate constant (ka) and
the dissociation rate constant (kd) were measured by using the software package FASTfitTM (Affinity Sensors, Cambridge, UK). KD(kin) was calculated from
Equation 1 (18-20).
At least two cuvettes were used to determine the various binding
constants, and the derived values differed by less than 10% between
the two measurements. The cuvettes were reused after cleaning with HCl.
Original binding curves could be replicated after HCl washes, implying
that the washing procedure used did not denature the bound ligand.
PCR Amplification of VARC and Nucleotide Sequence
Analysis--
Oligonucleotide primers, designed using the
var2 nucleotide sequence reported by Su et. al.
(11), were used to amplify the VARC region of var genes from
P. falciparum genomic DNA (line ItG2). Resultant DNA
fragments were cloned into the E. coli cloning vector pUC18
(22), and the nucleotide sequence of two of these amplification
products, VARC1 and VARC2, was determined. Both VARC1 and VARC2
nucleotide sequences showed significant similarity to each other and
other VARC regions reported in sequence data bases (data not shown).
Recombinant Protein Expression and Purification--
VARC1 and
PCR-amplified regions of KAHRP were cloned into the E. coli
pGEX protein expression plasmids. Fragments from the second exon of
KAHRP were used in these experiments because we have been unable to
express full-length recombinant KAHRP in usable amounts (data not
shown). The first exon of KAHRP was not examined for VARC binding
regions because it encodes a predominantly hydrophobic region believed
to be a signal sequence that is cleaved from the mature polypeptide
(23). The various GST-KAHRP fusion proteins used in the protein-protein
binding assays are shown in Fig. 1.
Binding of VARC to K1, K2, and K3--
Initial binding assays were
performed using the GST-KAHRP fusion proteins GST-K1, GST-K2, and
GST-K3. Approximately 3 µg of total protein wase added per well
followed by blocking of nonspecific protein-plastic interactions with
BSA in PBS. 5 µg of purified GST-VARC1 was then added to each well.
After removal of nonspecifically bound GST-VARC1, proteins remaining in
the wells were removed by stripping the wells with SDS sample buffer,
subjected to SDS-polyacrylamide gel electrophoresis before transfer to
membrane. Immunoblot detection of GST-VARC1 was performed using a
polyclonal rabbit anti-GST-VARC1 antiserum (preabsorbed to remove
anti-GST reactivity). Fig. 2 shows the
immunoblot results of such a binding assay. GST-VARC1 (full length
~97 kDa) was detected binding to each of the GST-K1, GST-K2, and
GST-K3 (lanes 1, 2, and 3) fusion
proteins. Smaller molecular mass immunoreactive GST-VARC1 bands were
detected in each lane using the anti-GST-VARC1 antiserum (preabsorbed
for anti-GST reactivity). Because these bands are immunoreactive with both anti-GST-VARC1 (preabsorbed for anti-GST reactivity) and anti-GST
antisera (data not shown) they most likely represent proteolytic
cleavage or premature termination products of full-length GST-VARC1.
GST-VARC1 was not detected binding to the control proteins, GST or BSA
(lanes 4 and 5). Thus each of the K1, K2, and K3
regions of KAHRP appeared to encode a separate domain capable of
binding the cytoplasmic tail of PfEMP1.
Fine Mapping of the VARC Binding Regions in KAHRP--
With the
data obtained in initial binding assays indicating the existence of
multiple regions in KAHRP able to bind VARC, we set out to map the
location of these binding regions more precisely by constructing a
series of protein expression clones encoding smaller fragments of the
KAHRP gene. For this series of experiments the KAHRP subclones K1A,
K1B, K1C, K1D, K2A, and K2B (Fig. 3) were
cloned into pGEX, and their corresponding GST fusion proteins were
expressed and purified (Fig. 1). Immunoblots of these binding assays
(Fig. 3) show binding of GST-VARC1 to several regions. GST-VARC1 binds
to GST-K1, and its subfragments GST-K1A (with minimal binding to
GST-K1B, and GST-K1D; lanes 1, 2, 3,
and 5, respectively), to GST-K2 and its subfragment GST-K2A
(lanes 6 and 7), and to GST-K3 (lane
9) as evidenced by the detection of a ~97-kDa band by the
anti-GST-VARC1 antiserum (preabsorbed for anti-GST reactivity). No
binding of GST-VARC1 was detected to GST-K1C, GST-K2B or the control
protein GST and BSA (lanes 4, 8, 10,
and 11, respectively). These data provided direct evidence for the existence of at least three VARC binding sites in KAHRP. These
VARC binding regions are encoded within K1A, K2A, and K3.
Although binding of GST-VARC1 to GST-K1 was detected, it is of
lesser intensity than the binding of GST-VARC1 to GST-K1A. This is
likely to be the result of the relatively lower amount of full-length
GST-K1 used compared with full-length GST-K1A (Fig. 1, lanes
1 and 2) resulting in the lower signal intensity
detected than, for example, full-length GST-K2 and GST-K2A, which are
both expressed as predominantly full-length products (Fig. 1,
lanes 6 and 7) and produce bands of similar intensity.
To determine the significance of the observed interactions, biophysical
data was obtained using an IAsysTM system in which the aminosilane
cuvettes were coated with GST, BSA, or GST-VARC1 proteins and the
GST-KAHRP fusions applied in aqueous solution. The
KD(kin) values determined for the interaction
between GST-VARC1 and GST-K1A, and GST-VARC1 and GST-K2A were 1 × 10 Deletion Mutagenesis and Confirmation of VARC Binding to Peptide
Repeat Regions in KAHRP--
Comparison of the locations of the K1A
and K2A regions to the KAHRP gene structure (Fig. 3) revealed that the
K1A and K2A regions contain peptide repeat regions (23). We wondered
whether the binding regions were located within these regions
particularly as they would be predominantly positively charged, and
VARC has regions of high net negative charge. To examine this, two
KAHRP mutants lacking the peptide repeats were generated by PCR, these being the K1
The removal of both the histidine-rich repeat region (63 amino acid
residues) in GST-K1 Modification of red cell properties during parasite infection has
been attributed to both the presence of parasite-encoded proteins at
the red blood cell cytoskeleton and parasite-induced changes to red
cell cytoskeletal proteins (for review, see Ref. 5). Perhaps the most
important acquired property is the capacity of red cells infected with
mature parasites to adhere to the vascular endothelium and
consequently, disappear from the peripheral circulation. This property
is implicated strongly in the causation of severe forms of P. falciparum infection such as cerebral malaria. The work presented
here suggests that the parasite adhesin PfEMP1 is anchored at the cell
membrane by interaction with KAHRP. KAHRP is a major component of
knobs, the electron-dense protuberances on the cytoplasmic face of the
infected red cell membrane (24, 25). This interaction helps explain why
PfEMP1 is found to be clustered at knobs (8). Previous work has
identified an association between KAHRP and spectrin and actin (4).
Thus the net effect of the interaction between KAHRP and PfEMP1 would
be to anchor indirectly PfEMP1 to the red cell membrane skeleton. This
indirect linkage is likely to be the explanation of why PfEMP1 has the solubility properties of a cytoskeletal protein being insoluble in the
non-ionic detergent Triton X-100 (25).
We have shown that multiple regions of KAHRP bind VARC and have mapped
two of these regions to peptide repeat domains comprised of 63 and 70 amino acid residues. We have also presented evidence of a third region
of KAHRP which binds VARC, although we believe that this region plays a
less significant role in the interaction of KAHRP and VARC than the 63- and 70-residue regions because of the lower affinity of interaction
(KD(kin) = 1.3 × 10 Determination of the affinities
(K(D)) for both GST-K1A and
GST-K2A binding to GST-VARC1 gave values indicative of moderate
affinity interactions: KD(kin) = 1 × 10 A prominent feature of many malaria proteins is the presence of
extensive regions of sequences repeated in tandem (32). It has been
quite difficult to assign functional roles to these repeat regions.
They are often the target of antibody-induced immunity in individuals
living in endemic areas (33), and it has been suggested that they act
as a form of immunological smoke screen diverting the immune system to
low affinity nonprotective antibody responses (34, 35). Occasionally,
additional roles have been suggested. For example, the repeats of the
circumsporozoite protein have been proposed to play some role in the
interaction of the sporozoite with the hepatocyte (36). However, more
recently the binding site has been mapped to nonrepetitive sequence
elsewhere in the circumsporozoite protein (37). Similarly, the binding site of a second sporozoite protein, thrombospondin-related anonymous protein, for hepatocytes has also been mapped to a region of
nonrepetitive sequence (38). The binding domains of RESA, MESA and
merozoite surface protein 1 mentioned above are all found in
nonrepetitive sequence (17, 29, 30). Although the 271-residue
spectrin/actin binding region of KAHRP does in fact contain the 5'
repeats (4), the interacting domain has not been mapped to a defined
peptide sequence within this region. In contrast, both high affinity
KAHRP binding domains for VARC identified in this study are mapped to defined repeat regions. The interaction of KAHRP with VARC is likely to
have an electrostatic component because at the pH of the infected red
cell (39), the overall charges on the histidine-rich and 5' repeats are
positive (+7 and +11, respectively), whereas the overall charge on VARC
is negative ( Increased knowledge of the interactions between malaria parasites and
their host red blood cells and between infected red cells and the
vascular endothelium may aid the development of new or improved drug
therapies. Infected red cells, particularly at later stages of parasite
maturation which are sequestered, exhibit increased membrane
permeability and as such should enable molecules capable of interfering
with the KAHRP-PfEMP1 interaction to enter the infected red blood cell
readily. Interference with the anchoring of PfEMP1 by inhibiting
its interaction with KAHRP would render parasites unable to sequester
in vivo by decreasing adhesive interactions with the
vascular interior and increasing destruction rates of infected red
cells in the spleen. This would have the effect of lowering
parasitaemia and thus decreasing the severity of disease and the
morbidity and mortality associated with P. falciparum malaria.
We thank Dr. Bill Bennett for providing KAHRP
gene fragments and Dr. Michael Foley for helpful discussions.
*
This work was supported by National Institutes of Health
Grant DK-32094 and the National Health and Medical Research Council.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) VARC1, AF100791; VARC2, AF100792.
§
Present address: Dept. of Biochemistry, School of Medicine, Tokyo
Women's Medical University, 8 1 Kwada-cho, Shinjuku, Tokyo 162 8666, Japan.
¶
To whom correspondence should be addressed. Tel.:
613-9905-4822; Fax: 613-9905-4811; E-mail:
ross.coppel@med.monash.edu.au.
The abbreviations used are:
KAHRP, knob-associated histidine-rich protein;
MESA, mature parasite-infected
erythrocyte surface antigen;
PfEMP, P. falciparum
erythrocyte membrane protein;
PCR, polymerase chain reaction;
GST, glutathione S-transferase;
PBS, phosphate-bufered saline;
BSA, bovine serum albumin;
KD(kin) and
KD(Scat), dissociation constants determined by
kinetic and Scatchard analysis, respectively;
RESA, ring-infected
erythrocyte surface antigen.
Mapping the Binding Domains Involved in the Interaction between
the Plasmodium falciparum Knob-associated Histidine-rich
Protein (KAHRP) and the Cytoadherence Ligand P. falciparum
Erythrocyte Membrane Protein 1 (PfEMP1)*
§,
, and
Life Sciences Division,
Lawrence Berkeley Laboratories, Berkeley, California 94720
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
7 M and 3.3 × 10
6 M respectively, values comparable to
those reported previously for protein-protein interactions in normal
and infected red cells. Further experiments localized the high affinity
binding regions of KAHRP to the 63-residue histidine-rich and
70-residue 5' repeats. Deletion of these two regions from the KAHRP
fragments abolished their ability to bind to VARC. Identification of
the critical domains involved in interaction between KAHRP and PfEMP1
may aid development of new therapies to prevent serious complications of P. falciparum malaria.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Oligonucleotide primers used in the construction of VARC and KAHRP
fragments
Dissociation constants by Scatchard analysis
(KD(Scat)) were also derived from the binding
data. The maximal extent of binding (Req) at
various concentrations of [B] were derived from the binding
curves.
(Eq. 1)
The slope of the plot of Req
versus Req/[B] provides the value
of
(Eq. 2)
KA. KD(Scat) is then
calculated.
In the present study, the KD(Scat)
derived under a variety of experimental conditions closely
matched the corresponding KD(kin) values calculated.
(Eq. 3)
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (30K):
[in a new window]
Fig. 1.
Purified GST-KAHRP fusion proteins. 2 µg of total purified GST fusion proteins was analyzed by
SDS-polyacrylamide gel electrophoresis in 10% or 12% polyacrylamide
gels and stained with Coomassie Brilliant Blue. The fusion proteins are
GST-K1 (lane 1), GST-K1A (lane 2), GST-K1B
(lane 3), GST-K1C (lane 4), GST-K1D (lane
5), GST-K2 (lane 6), GST-K2A (lane 7),
GST-K2B (lane 8), GST-K3 (lane 9), GST
(lane 10), GST-K1
his (lane 12), and
GST-K2
5' (lane 13).

View larger version (27K):
[in a new window]
Fig. 2.
Initial mapping of VARC binding regions in
KAHRP. The P. falciparum KAHRP gene contains two exons
separated by an intron (panel A). The first exon encodes a
putative signal sequence, containing a hydrophobic core, which is
thought to be cleaved from the mature KAHRP protein. The second exon
contains three peptide repeat regions: the histidine-rich repeats, the
5' repeats, and the 3' repeats (23). Amino acid residue numbers are
shown adjacent to the protein schematic and KAHRP fragment names to
indicate locations of important peptide repeat regions and lengths of
fragments. Binding assay immunoblots, detected using polyclonal rabbit
anti-GST-VARC1 antisera (preabsorbed for anti-GST reactivity) are shown
in panel B. GST-VARC1 (~97 kDa) was detected binding to
GST-K1, GST-K2, and GST-K3 (lanes 1, 2, and
3) but not to control proteins GST and BSA (lanes
4 and 5).

View larger version (45K):
[in a new window]
Fig. 3.
Finer mapping of the VARC binding regions in
KAHRP. The locations of the smaller KAHRP subfragments are shown
in relation to their location in the KAHRP gene (panel A).
Amino acid residue numbers are shown adjacent to the protein schematic
and KAHRP fragment names. Binding assay immunoblots (panel
B) showed GST-VARC1 (~97 kDa) bound to GST-K1 (lane
1), GST-K1A (lane 2), GST-K2 (lane 6),
GST-K2A (lane 7), and GST-K3 (lane 9). Little or
no binding of GST-VARC1 was detected for GST-K1B, GST-K1C, GST-K1D
(lanes 3, 4, and 5), GST-K2B
(lane 8), GST and BSA (lanes 10 and
11).
7 M and 3.3 × 10
6
M, respectively, whereas the interaction of GST-VARC1 and
GST-K3 gave a KD(kin) = 1.3 × 10
5 M (Table
II). Other subfragments of K1 and K2 and
the GST and BSA control proteins gave no detectable binding in this
system (data not shown). It is noteworthy that the binding constants for K2 and K2A (Table II) are very similar, suggesting that essentially all binding sequences of K2 are found in K2A. Similar values were obtained when the binding of these fragments was examined using a
procedure that provides KD(Scat). The
concordance of the estimates is good, giving confidence in the derived
values.
VARC binding sites of KAHRP
histidine-rich repeats and K2
5' repeats (designated K1
his and K2
5', respectively) and cloned into the pGEX protein expression plasmids. Recombinant GST fusion proteins were expressed and
purified (Fig. 1) and then used in binding assays to demonstrate the
effect of removal of these repeat regions on the ability of K1 and K2
to bind VARC. In these assays, the amount of GST-K1 added to the wells
was corrected for the low amount of full-length GST-K1 present in the
purified sample (Fig. 1). We increased the amount of GST-K1 added
3-fold so that approximately equivalent amounts of full-length GST-K1
and GST-K1A proteins were being added to the wells.
his and the 5' repeats (70 residues) in
GST-K2
5' resulted in the complete absence of GST-VARC1 binding to
these mutant proteins (Fig. 4,
panel B, lane 3; panel C, lane 8), whereas binding to the KAHRP fragments retaining these peptide repeat regions was observed (Fig. 4, panel B, lanes
1 and 2; panel C, lanes 6 and
7). Binding experiments performed using the IAsysTM confirmed that GST-VARC1 did not bind to either GST-K1
his or GST-K2
5' fusion proteins (Table II). These data not only confirm that there are at least two VARC binding regions in KAHRP, but they
localize these VARC binding regions of KAHRP to within 63 and 70 amino
acid residues. Interestingly, the signal detected for GST-VARC1 binding
to both GST-K1 and GST-K1A appears to have been equalized (Fig. 4,
panel B, lanes 1 and 2) by the
adjustment made to correct for the amount of full-length protein coated
onto the wells.

View larger version (42K):
[in a new window]
Fig. 4.
Binding of GST-VARC1 to GST-KAHRP deletion
mutants. The KAHRP mutants, K1
histidine repeats (K1
his) and
K2
5' repeats (K2
5') are shown with respect to their locations in
the KAHRP gene (panel A). Amino acid residue numbers are
shown adjacent to the protein schematic and KAHRP fragment names.
Binding assay immunoblots showed GST-VARC1 (~97 kDa) bound to GST-K1
and GST-K1A (panel B, lanes 1 and 2)
but not to the KAHRP deletion mutant GST-K1
his (lane 3).
Similarly, GST-VARC1 bound to GST-K2 and GST-K2A (panel C,
lanes 6 and 7) but not to the GST-K2
5' KAHRP
mutant (lane 8). In both of these assays there was little or no
GST-VARC1 bound to the control proteins GST and BSA (panel
B, lanes 4 and 5, and panel C,
lanes 9 and 10).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
5
M). Such relatively short sequences make it likely that the
binding motifs have a linear nature. The identification of multiple
regions in KAHRP which bind VARC contrasts with other studies focused on interactions between parasite proteins and host proteins of the red
cell membrane skeleton. For example, the interaction between MESA,
which is localized on the cytoplasmic side of the red cell membrane
(26), and the red cell cytoskeletal protein, protein 4.1 (27) has been
localized to 19 residues located in the NH2-terminal region
of MESA (17). The ring-infected erythrocyte surface antigen (RESA),
which associates with the red cell cytoskeletal protein spectrin (28),
contains a single 48-residue spectrin binding domain (29), whereas a
30-residue domain confers binding of merozoite surface protein 1 to
spectrin (30). Mapping studies of KAHRP binding to the red cell
cytoskeletal proteins spectrin and actin are less advanced with the
binding domain localized to a 271-residue binding region that has not
been further characterized (4).
7 M and KD(kin) = 3.3 × 10
6 M, respectively. A value of
KD(kin) = 1.3 × 10
5
M was obtained for the binding of GST-K3 to GST-VARC1,
indicating an interaction of less significance than the aforementioned
regions. Comparison of these K(D)
values with those obtained for other protein-protein interactions at
the membrane of normal and infected red cells reveals that they are
within the range of previously determined
K(D) values. The binding of normal
red cell cytoskeletal proteins spectrin and band 2.1 was measured at
KD
10
7 M, whereas
binding between spectrin and band 4.1 returned a similar affinity
(KD
10
7 M) (31).
The KD(Scat) obtained for the binding between the parasite protein MESA and its partner protein 4.1 was found to be
(6.3 ± 1.2) × 10
7 M (17). The K1A
and K2A regions contribute individually to the interaction between
KAHRP and VARC at affinities comparable to the single binding domains
identified in spectrin-protein 4.1, spectrin-band 2.1, and MESA-protein
4.1. When considering the data obtained for each of K1A, K2A and K3 in
conjunction with one another, its seems reasonable that the three
regions may act cooperatively to result in an interaction of very high
affinity. One caveat is that in the absence of a three-dimensional
structure for KAHRP, it is not known whether it is possible for all
three regions of KAHRP to interact with a single VARC. However, it is also possible that the three regions could react with separate VARC
molecules providing a cross-linking effect that would serve to anchor a
number of PfEMP1 molecules in a compact space. This would provide a
high density of PfEMP1 ectodomains at the knob and improve binding
affinity for endothelial cells. Perhaps it is the loss of clustering of
PfEMP1 in the absence of knobs which explains the loss of adherence of
knobless infected red cells under flow conditions while their binding
ability appears to be maintained in the absence of flow-induced
hemodynamic stress. Alternatively, the weakened adhesive properties may
be caused by PfEMP1 being "pulled" out of the membrane of infected
red cells, due to inadequate anchoring, when subjected to the
physiological shear stresses that occur in the circulation in
vivo.
28). Allelic variation of KAHRP between different
parasite isolates has revealed that the COOH-terminal region of KAHRP
including the 3' repeats is much more highly variable than the
histidine-rich and 5' repeats (40, 41). Thus it appears as if there are
greater constraints on variation of the histidine-rich and 5' repeats,
and this may be because of their involvement in binding interactions
with PfEMP1 and its role in aiding parasite survival by permitting
adhesion and sequestration of infected red cells.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Macpherson, G. G.,
Warrell, M. J.,
White, N. J.,
Looareesuwan, S.,
and Warrell, D. A.
(1985)
Am. J. Pathol.
119,
385-401[Abstract]
2.
Berendt, A. R.,
Ferguson, D. J. P.,
Gardner, J.,
Turner, G.,
Rowe, A.,
McCormick, C.,
Roberts, D.,
Craig, A.,
Pinches, R.,
Elford, B. C.,
and Newbold, C. I.
(1994)
Parasitology
108,
S19-S28
3.
Crabb, B. S.,
Triglia, T.,
Waterkeyn, J. G.,
and Cowman, A. F.
(1997)
Mol. Biochem. Parasitol.
90,
131-144[CrossRef][Medline]
[Order article via Infotrieve]
4.
Kilejian, A.,
Rashid, M. A.,
Aikawa, M.,
Aji, T.,
and Yang, Y.-F.
(1991)
Mol. Biochem. Parasitol.
44,
175-182[CrossRef][Medline]
[Order article via Infotrieve]
5.
Coppel, R. L.,
Cooke, B. M.,
Magowan, C.,
and Mohandas, N.
(1998)
Curr. Opin. Hematol.
5,
132-138[Medline]
[Order article via Infotrieve]
6.
Leech, J. H.,
Barnwell, J. W.,
Miller, L. H.,
and Howard, R. J.
(1984)
J. Exp. Med
159,
1567-1575 7.
Howard, R. J.,
Barnwell, J. W.,
Rock, E. P.,
Neequaye, J.,
Ofori-Adjei, D.,
Lyon, J. A.,
and Saul, A.
(1988)
Mol. Biochem. Parasitol.
27,
207-224[CrossRef][Medline]
[Order article via Infotrieve]
8.
Baruch, D. I.,
Pasloske, B. L.,
Singh, H. B.,
Bi, X.,
Ma, X. C.,
Feldman, M.,
Taraschi, T. F.,
and Howard, R. J.
(1995)
Cell
82,
77-87[CrossRef][Medline]
[Order article via Infotrieve]
9.
Baruch, D. I.,
Gormely, J. A.,
Ma, C.,
Howard, R. J.,
and Pasloske, B. L.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
3497-3502 10.
Rubio, J. P.,
Thompson, J. K.,
and Cowman, A. F.
(1996)
EMBO J.
15,
4069-4077[Medline]
[Order article via Infotrieve]
11.
Su, X.,
Heatwole, V. M.,
Wertheimer, S. P.,
Guinet, F.,
Herrfeldt, J. A.,
Peterson, D. S.,
Ravetch, J. A.,
and Wellems, T. E.
(1995)
Cell
82,
89-100[CrossRef][Medline]
[Order article via Infotrieve]
12.
Bonnefoy, S.,
Bischoff, E.,
Guillotte, M.,
and Mercereau-Puijalon, O.
(1997)
Mol. Biochem. Parasitol.
87,
1-11[CrossRef][Medline]
[Order article via Infotrieve]
13.
Aley, S. B.,
Sherwood, J. A.,
and Howard, R. J.
(1984)
J. Exp. Med
160,
1585-1590 14.
Pologe, L. G.,
and Ravetch, J. V.
(1986)
Nature
322,
474-477[CrossRef][Medline]
[Order article via Infotrieve]
15.
Crabb, B. S.,
Cooke, B. M.,
Reeder, J. C.,
Waller, R. F.,
Caruana, S. R.,
Davern, K. M.,
Wickham, M. E.,
Brown, G. V.,
Coppel, R. L.,
and Cowman, A. F.
(1997)
Cell
89,
287-296[CrossRef][Medline]
[Order article via Infotrieve]
16.
Ruangjirachuporn, W.,
Afzelius, B. A.,
Paulie, S.,
Wahlgren, M.,
Berzins, K.,
and Permann, P.
(1991)
Parasitology
102,
325-334
17.
Bennett, B. J.,
Mohandas, N.,
and Coppel, R. L.
(1997)
J. Biol. Chem.
272,
15299-15306 18.
Cush, R.,
Cronin, J. M.,
Stewart, W. J.,
Maule, C. H.,
Molloy, J.,
and Goddard, N. J.
(1993)
Biosens. Bioelect.
8,
347-353
19.
Watts, H. J.,
Lowe, C. R.,
and Pollard-Knight, D. V.
(1994)
Anal. Chem.
66,
2465-2470[Medline]
[Order article via Infotrieve]
20.
George, A. J. T.,
French, R. R.,
and Glennie, M. J.
(1995)
J. Immunol. Methods
183,
51-63[CrossRef][Medline]
[Order article via Infotrieve]
21.
Nunomura, W.,
Takakuwa, Y.,
Tokimitsu, R.,
Krauss, S. W.,
Kawashima, M.,
and Mohandas, N.
(1997)
J. Biol. Chem.
272,
30322-30328 22.
Vieira, J.,
and Messing, J.
(1982)
Gene (Amst.)
19,
259-268[CrossRef][Medline]
[Order article via Infotrieve]
23.
Triglia, T.,
Stahl, H.-D.,
Crewther, P. E.,
Scanlon, D.,
Brown, G. V.,
Anders, R. F.,
and Kemp, D. J.
(1987)
EMBO J.
6,
1413-1419[Medline]
[Order article via Infotrieve]
24.
Kilejian, A.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4650-4653 25.
Leech, J. H.,
Barnwell, J. W.,
Aikawa, M.,
Miller, L. H.,
and Howard, R. J.
(1984)
J. Cell Biol.
98,
1256-1264 26.
Coppel, R. L.,
Culvenor, J. G.,
Bianco, A. E.,
Crewther, P. E.,
Stahl, H.-D.,
Brown, G. V.,
Anders, R. F.,
and Kemp, D. J.
(1986)
Mol. Biochem. Parasitol.
20,
265-277[CrossRef][Medline]
[Order article via Infotrieve]
27.
Lustigman, S.,
Anders, R. F.,
Brown, G. V.,
and Coppel, R. L.
(1990)
Mol. Biochem. Parasitol.
38,
261-270[CrossRef][Medline]
[Order article via Infotrieve]
28.
Foley, M.,
Tilley, L.,
Sawyer, W. H.,
and Anders, R. F.
(1991)
Mol. Biol. Chem.
46,
137-148
29.
Foley, M.,
Corcoran, L.,
Tilley, L.,
and Anders, R. F.
(1994)
Exp. Parasitol.
79,
340-350[CrossRef][Medline]
[Order article via Infotrieve]
30.
Herrera, S.,
Rudin, W.,
Herrera, M.,
Clavijo, P.,
Mancilla, L.,
de Plata, C.,
Matile, H.,
and Certa, U.
(1993)
EMBO J.
12,
1607-1614[Medline]
[Order article via Infotrieve]
31.
Tyler, J. M.,
Reinhardt, B. N.,
and Branton, D.
(1980)
J. Biol. Chem.
255,
7034-7039 32.
Anders, R. F.,
Barzaga, N.,
Shi, P.-T.,
Scanlon, D. B.,
Brown, L. E.,
Thomas, L. M.,
Brown, G. V.,
Stahl, H. D.,
Coppel, R. L.,
and Kemp, D. J.
(1987)
UCLA Symp. Mol. Cell. Biol. New Ser.
42,
333-342
33.
Anders, R. F.,
Coppel, R. L.,
Brown, G. V.,
and Kemp, D. J.
(1988)
Prog. Allergy
41,
148-172[Medline]
[Order article via Infotrieve]
34.
Coppel, R. L.,
Cowman, A. F.,
Lingelbach, K. R.,
Brown, G. V.,
Saint, R. B.,
Kemp, D. J.,
and Anders, R. F.
(1983)
Nature
306,
751-756[CrossRef][Medline]
[Order article via Infotrieve]
35.
Anders, R. F.
(1986)
Parasite Immunol. (Oxf.)
8,
529-539
36.
Aley, S. B.,
Bates, M. D.,
Tam, J. P.,
and Hollingdale, M. R.
(1986)
J. Exp. Med.
164,
1915-1922 37.
Cerami, C.,
Frevert, U.,
Sinnis, P.,
Takacs, B.,
Clavijo, P.,
Santos, M. J.,
and Nussenzweig, V.
(1992)
Cell
70,
1021-1033[CrossRef][Medline]
[Order article via Infotrieve]
38.
Muller, H. M.,
Reckman, I.,
Hollingdale, M. R.,
Bujard, H.,
Robson, K. J.,
and Crisanti, A.
(1993)
EMBO J.
12,
2881-2889[Medline]
[Order article via Infotrieve]
39.
Yayon, A.,
Cabantchik, Z. I.,
and Ginsburg, H.
(1984)
EMBO J.
3,
2695-2700[Medline]
[Order article via Infotrieve]
40.
Kant, R.,
and Sharma, Y. D.
(1996)
FEBS Lett.
380,
147-151[CrossRef][Medline]
[Order article via Infotrieve]
41.
Hirawake, H.,
Kita, K.,
and Sharma, Y. D.
(1997)
Biochim. Biophys. Acta
1360,
105-108[Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Rug, S. W. Prescott, K. M. Fernandez, B. M. Cooke, and A. F. Cowman The role of KAHRP domains in knob formation and cytoadherence of P falciparum-infected human erythrocytes Blood, July 1, 2006; 108(1): 370 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marti, J. Baum, M. Rug, L. Tilley, and A. F. Cowman Signal-mediated export of proteins from the malaria parasite to the host erythrocyte J. Cell Biol., November 21, 2005; 171(4): 587 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Pei, X. An, X. Guo, M. Tarnawski, R. Coppel, and N. Mohandas Structural and Functional Studies of Interaction between Plasmodium falciparum Knob-associated Histidine-rich Protein (KAHRP) and Erythrocyte Spectrin J. Biol. Chem., September 2, 2005; 280(35): 31166 - 31171. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Horrocks, R. A. Pinches, S. J. Chakravorty, J. Papakrivos, Z. Christodoulou, S. A. Kyes, B. C. Urban, D. J. P. Ferguson, and C. I. Newbold PfEMP1 expression is reduced on the surface of knobless Plasmodium falciparum infected erythrocytes J. Cell Sci., June 1, 2005; 118(11): 2507 - 2518. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Knuepfer, M. Rug, N. Klonis, L. Tilley, and A. F. Cowman Trafficking of the major virulence factor to the surface of transfected P falciparum-infected erythrocytes Blood, May 15, 2005; 105(10): 4078 - 4087. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Topolska, A. Lidgett, D. Truman, H. Fujioka, and R. L. Coppel Characterization of a Membrane-associated Rhoptry Protein of Plasmodium falciparum J. Biol. Chem., February 6, 2004; 279(6): 4648 - 4656. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Spycher, N. Klonis, T. Spielmann, E. Kump, S. Steiger, L. Tilley, and H.-P. Beck MAHRP-1, a Novel Plasmodium falciparum Histidine-rich Protein, Binds Ferriprotoporphyrin IX and Localizes to the Maurer's Clefts J. Biol. Chem., September 12, 2003; 278(37): 35373 - 35383. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Waller, W. Nunomura, X. An, B. M. Cooke, N. Mohandas, and R. L. Coppel Mature parasite-infected erythrocyte surface antigen (MESA) of Plasmodium falciparum binds to the 30-kDa domain of protein 4.1 in malaria-infected red blood cells Blood, September 1, 2003; 102(5): 1911 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Glenister, R. L. Coppel, A. F. Cowman, N. Mohandas, and B. M. Cooke Contribution of parasite proteins to altered mechanical properties of malaria-infected red blood cells Blood, February 1, 2002; 99(3): 1060 - 1063. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||